1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. JAZZ PHARMACEUTICALS PLC
Jazz Pharmaceuticals plc XNAS: JAZZ

Jazz Pharmaceuticals plc Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav...

Read More
131.72 2.06 (1.59%)
37.94% Gain from 52W Low
654.9K
XNAS Volume

XNAS 03 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The latest board meeting for Jazz Pharmaceuticals plc took place on 03 Sep 2025, for the purpose of Jazz Pharmaceuticals at 2025 Wells Fargo Healthcare Conference See details
Durability score
Medium Financial Strength
38.9 / 100
Valuation Score
Mid Valuation
37.5 / 100
Momentum Score
Technically Neutral
52.8 / 100
Mid-range Performer These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks. View Similar Embed DVM
Analyst Price Target
186
1Yr Price target upside is 42%
17 analysts

17

S

3

W

0

O

3

T

SWOT Analysis

Jazz Pharmaceuticals plc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..